BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 31395346)

  • 1. Epigenetic regulation of DNA repair genes and implications for tumor therapy.
    Christmann M; Kaina B
    Mutat Res Rev Mutat Res; 2019; 780():15-28. PubMed ID: 31395346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents.
    Bearzatto A; Szadkowski M; Macpherson P; Jiricny J; Karran P
    Cancer Res; 2000 Jun; 60(12):3262-70. PubMed ID: 10866320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis.
    Esteller M; Risques RA; Toyota M; Capella G; Moreno V; Peinado MA; Baylin SB; Herman JG
    Cancer Res; 2001 Jun; 61(12):4689-92. PubMed ID: 11406538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients.
    Saikia S; Rehman AU; Barooah P; Sarmah P; Bhattacharyya M; Deka M; Deka M; Goswami B; Husain SA; Medhi S
    Tumour Biol; 2017 May; 39(5):1010428317701630. PubMed ID: 28468586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic silencing of the MGMT gene in cancer.
    Soejima H; Zhao W; Mukai T
    Biochem Cell Biol; 2005 Aug; 83(4):429-37. PubMed ID: 16094446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
    Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
    J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
    Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
    Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer.
    Gao D; Herman JG; Guo M
    Oncotarget; 2016 Jun; 7(24):37331-37346. PubMed ID: 26967246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer.
    Stefansson OA; Hermanowicz S; van der Horst J; Hilmarsdottir H; Staszczak Z; Jonasson JG; Tryggvadottir L; Gudjonsson T; Sigurdsson S
    BMC Cancer; 2017 Jul; 17(1):469. PubMed ID: 28679371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins.
    Danam RP; Howell SR; Brent TP; Harris LC
    Mol Cancer Ther; 2005 Jan; 4(1):61-9. PubMed ID: 15657354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
    Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
    Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation aberrancies as a guide for surveillance and treatment of human cancers.
    Liang G; Weisenberger DJ
    Epigenetics; 2017 Jun; 12(6):416-432. PubMed ID: 28358281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes.
    Esteller M
    Eur J Cancer; 2000 Dec; 36(18):2294-300. PubMed ID: 11094302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic drivers of genetic alterations.
    Toyota M; Suzuki H
    Adv Genet; 2010; 70():309-23. PubMed ID: 20920753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells.
    Ji W; Yang L; Yu L; Yuan J; Hu D; Zhang W; Yang J; Pang Y; Li W; Lu J; Fu J; Chen J; Lin Z; Chen W; Zhuang Z
    Carcinogenesis; 2008 Jun; 29(6):1267-75. PubMed ID: 18204074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutator pathways unleashed by epigenetic silencing in human cancer.
    Jacinto FV; Esteller M
    Mutagenesis; 2007 Jul; 22(4):247-53. PubMed ID: 17412712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of the alterations in DNA methylation in esophageal squamous cell carcinoma.
    Baba Y; Watanabe M; Baba H
    Surg Today; 2013 Dec; 43(12):1355-64. PubMed ID: 23291904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic silencing of the DNA repair enzyme O6-methylguanine-DNA methyltransferase in Mex- human cells.
    Cairns-Smith S; Karran P
    Cancer Res; 1992 Oct; 52(19):5257-63. PubMed ID: 1394130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.